Lexogen

Established in 2007, Lexogen is a global leading company in transcriptomics, next-generation sequencing, RNA analysis, and bioinformatics. Lexogen is the leader in 3’ mRNA sequencing, a technology proven for its efficiency, its robustness, and its sensitivity.

Lexogen’s portfolio includes innovative kits developed and produced in Vienna, Austria, for true single-cell as well as bulk RNA sequencing, RNA extraction, ribosomal RNA depletion, spike-in RNA variant controls, and nascent RNA labeling for transcriptome-wide analysis of RNA kinetics. Lexogen also provides first-class, fully integrated, customizable NGS services, from experimental design consulting to sample processing and tailored bioinformatics analysis and reporting.

Lexogen is a privately held company headquartered in Vienna, Austria, with a subsidiary in New Hampshire, USA.